Avoro Capital Advisors LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.7T
Holdings
44
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 9,000,000 | $842.8B | 14.66% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 5,000,000 | $807.6B | 14.05% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 3,000,000 | $538.2B | 9.36% | |
| 4 | XLRNACCELERON PHARMA INC | 3,000,000 | $376.5B | 6.55% | |
| 5 | ARGXARGENX SE | 946,500 | $285.0B | 4.96% | |
| 6 | ARNAEURARENA PHARMACEUTICALS INC | 4,075,000 | $277.9B | 4.83% | |
| 7 | ASNDASCENDIS PHARMA | 1,900,000 | $249.9B | 4.35% | |
| 8 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,100,000 | $236.8B | 4.12% | |
| 9 | SRPTSAREPTA THERAPEUTICS INC | 2,400,000 | $186.6B | 3.25% | |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC | 1,150,000 | $170.9B | 2.97% | Call |
| 11 | VRTXVERTEX PHARMACEUTICALS INC | 790,000 | $159.3B | 2.77% | |
| 12 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,425,000 | $138.8B | 2.41% | |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,650,000 | $137.7B | 2.39% | |
| 14 | AM6AMICUS THERAPEUTICS INC | 12,450,000 | $120.0B | 2.09% | |
| 15 | —CONSTELLATION PHARMACEUTICALS INC | 3,210,000 | $108.5B | 1.89% | |
| 16 | —MERSANA THERAPEUTICS INC | 6,800,000 | $92.3B | 1.61% | |
| 17 | KURAKURA ONCOLOGY INC | 4,140,000 | $86.3B | 1.50% | |
| 18 | XENEXENON PHARMACEUTICALS INC | 3,650,000 | $68.0B | 1.18% | |
| 19 | APLSAPELLIS PHARMACEUTICALS INC | 1,245,230 | $66.9B | 1.16% | Call |
| 20 | PMVPPMV PHARMACEUTICALS INC | 1,825,000 | $62.3B | 1.08% | |
| 21 | GLUEMONTE ROSA THERAPEUTICS INC | 3,311,434 | $62.2B | 1.08% | |
| 22 | ACADACADIA PHARMACEUTICALS INC | 2,441,658 | $59.6B | 1.04% | |
| 23 | MRNS*MARINUS PHARMACEUTICALS INC | 3,235,000 | $58.0B | 1.01% | |
| 24 | TREURTRILLIUM THERAPEUTICS INC | 5,700,000 | $55.3B | 0.96% | |
| 25 | SNDXSYNDAX PHARMACEUTICALS INC | 3,000,000 | $51.5B | 0.90% | |
| 26 | MNKDMANNKIND CORP | 8,630,000 | $47.0B | 0.82% | |
| 27 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $44.9B | 0.78% | |
| 28 | OPHTEURIVERIC BIO INC | 6,425,000 | $40.5B | 0.71% | |
| 29 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 1,068,000 | $39.1B | 0.68% | |
| 30 | RLMDRELMADA THERAPEUTICS INC | 935,000 | $29.9B | 0.52% | |
| 31 | AVDLAVADEL PHARMACEUTICALS PLC | 4,365,000 | $29.4B | 0.51% | |
| 32 | PRAXPRAXIS PRECISION MEDICINES INC | 1,600,000 | $29.2B | 0.51% | |
| 33 | DSGNDESIGN THERAPEUTICS INC | 1,468,318 | $26.4B | 0.46% | |
| 34 | AMRNAMARIN CORP PLC | 6,000,000 | $26.3B | 0.46% | |
| 35 | OLMAOLEMA PHARMACEUTICALS INC | 876,986 | $24.5B | 0.43% | |
| 36 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $24.3B | 0.42% | |
| 37 | MRUSMERUS N V | 660,000 | $13.9B | 0.24% | |
| 38 | RNAAVIDITY BIOSCIENCES INC | 545,000 | $13.5B | 0.23% | |
| 39 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $12.2B | 0.21% | |
| 40 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $11.9B | 0.21% | |
| 41 | CNTACENTESSA PHARMACEUTICALS PLC | 500,000 | $11.1B | 0.19% | |
| 42 | —BCTG ACQUISITION CORP | 800,000 | $9.1B | 0.16% | |
| 43 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 2,024,400 | $8.6B | 0.15% | |
| 44 | —AERPIO PHARMACEUTICALS INC | 4,500,000 | $7.6B | 0.13% |